Login
HARVARD BIOSCIENCE INC logo

HARVARD BIOSCIENCE INC

harvardbioscience.com

What Do They Do?

Sells life science research instruments, software and consumables to pharmaceutical and biotechnology companies, laboratories and contract research organizations.

How Do They Make Money?

Customers generally place purchase orders for instruments, equipment and accessories, which are typically paid for when the products ship. They pay separately for services when performed and for maintenance and warranty contracts over the service period.

revenue
SegmentShareRevenue
Instruments, Equipment, Software, and Accessories
Sold outright

90%
FY2022: 95%
Service, Maintenance, and Warranty Contracts
9.6%
FY2022: 4.6%

Who Are Their Customers?

Sales reach end users through direct sales and distributors in the United States, China and major European markets; original equipment makers also incorporate products into offerings under their own brands.

Do Revenues Turn Into Profits?

Not on paper. It lost $56.7M in FY2025, but brought in more cash than it spent: $5.5M of free cash flow.

Operating income, FY2025
−56% of revenue
▼ −682% (Loss) vs FY2024 (−$6.2M, −7%)
Net income, FY2025
−66% of revenue
▼ −357% (Loss) vs FY2024 (−$12.4M, −13%)
Free cash flow, FY2025
6% of revenue
▲ Turned profitable vs FY2024 (−$1.2M, −1%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▲ +8%
vs $20.6M in Q3 FY2025
Net income
▼ −113% (Loss)
vs −$1.2M in Q3 FY2025
Instruments, Equipment, Software, and Accessories share of revenue vs 90.2% in Q3 FY2025

Shrinking. Revenue fell 27% in 4 years, from $118.9M in FY2021 to $86.6M in FY2025, about 8% a year.

More focus on organoid research The latest report describes products for organoid research, including MeshMEA, and a strategy to build offerings across in vivo and in vitro research. The older report described the product families and research uses without this organoid-focused strategy.

Consumables and software The latest report describes a strategy to shift toward consumables and software and increase recurring revenue. The older report described products augmented with consumables, software and services, but did not describe that strategic focus.

Revenue over time
Instruments, Equipment, Software, and Accessories Service, Maintenance, and Warranty Contracts
$200M$100M$0

Who Do They Compete With?

Competes with Agilent, Becton, Dickinson and, Bio-Rad Laboratories, Danaher, Emka Technologies, Eppendorf, Hitachi, Instem, Kent Scientific, Lonza Group, Revvity, Thermo Fisher Scientific, TSE Systems, and Waters

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support